image
Revolution Medicines, Inc. RVMD
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 55.13
-3.9 %
$ 9.27 B
Market Cap
-15.06
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 -67.27% -75.46% -88.63%
Annual Report FY 10-K 2022-12-31 20.38% -38.35% -37.38%
Annual Report FY 10-K 2021-12-31 -31.62% -66.21% -69.84%
Annual Report FY 10-K 2020-12-31 -14.10% -126.92% -104.54%
Annual Report FY 10-K 2019-12-31 148.16% -14.06% -34.20%
Annual Report FY 10-K 2018-12-31 0.00% -34.25% -29.55%
Annual Report FY 10-K 2017-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2024-09-30 0.00% -44.13% -42.57%
Quarterly Report Q2 8-K 2024-06-30 0.00% -35.54% -43.98%
Quarterly Report Q1 8-K 2024-03-31 0.00% -98.28% -87.42%
Quarterly Report Q4 8-K 2023-12-31 -95.16% -185.87% -191.67%
Quarterly Report Q3 8-K 2023-09-30 0.00% -47.87% -61.04%
Quarterly Report Q2 8-K 2023-06-30 -58.05% -62.87% -75.23%
Quarterly Report Q1 8-K 2023-03-31 -7.44% -2.02% -29.70%
Quarterly Report Q4 8-K 2022-12-31 62.05% -7.27% -16.62%
Quarterly Report Q3 8-K 2022-09-30 204.81% -38.51% -43.96%
Quarterly Report Q2 8-K 2022-06-30 4.81% -36.24% -39.42%
Quarterly Report Q1 8-K 2022-03-31 -25.20% -54.25% -54.96%
Quarterly Report Q4 8-K 2021-12-31 8.10% -54.01% -55.26%
Quarterly Report Q3 8-K 2021-09-30 -91.30% -94.48% -92.96%
Quarterly Report Q2 8-K 2021-06-30 -13.24% -62.77% -59.14%
Quarterly Report Q1 8-K 2021-03-31 -12.26% -90.46% -77.39%
Quarterly Report Q4 8-K 2020-12-31 -27.61% -134.34% -74.20%
Quarterly Report Q3 8-K 2020-09-30 1.24% -112.37% -103.19%
Quarterly Report Q2 8-K 2020-06-30 -18.37% -168.95% -164.97%
Quarterly Report Q1 8-K 2020-03-31 -12.30% -92.67% -102.01%
Quarterly Report Q4 8-K 2019-12-31 16.83% -28.72% -67.66%
Quarterly Report Q3 8-K 2019-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2019-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2019-03-31 0.00% 0.00% 0.00%
Quarterly Report Q4 8-K 2018-12-31 0.00% 0.00% 0.00%